• Keyvan Karkouti, Duminda N Wijeysundera, Terrence M Yau, W Scott Beattie, Esamelden Abdelnaem, Stuart A McCluskey, Mohammed Ghannam, Eric Yeo, George Djaiani, and Jacek Karski.
• Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada. keyvan.karkouti@uhn.on.ca
• Transfusion. 2004 Oct 1; 44 (10): 1453-62.

BackgroundAlthough the association between massive perioperative blood loss (MBL) and adverse outcomes is well recognized, it is unclear whether MBL is an independent risk factor or, instead, simply a marker for other adverse events or severity of illness. The objective of this cohort study was to quantify the independent association of MBL in cardiac surgery with all-cause in-hospital mortality.Study Design And MethodsData were prospectively collected on consecutive patients who underwent cardiac surgery with cardiopulmonary bypass at a quaternary-care academic center from 1999 to 2003. The number of red blood cell (RBC) units transfused within 1 day of surgery was used as a surrogate measure of perioperative blood loss. Receiver-operating characteristic curve analyses were employed to identify the most appropriate cutoff for defining MBL. The independent association of MBL with mortality was determined with multivariable logistic regression analyses. Bootstrapping and sensitivity analyses were used to confirm the validity of the results.ResultsMBL was defined as receiving at least 5 units of RBCs within 1 day of surgery. Of 9215 patients analyzed, 1.8 percent (n = 169) died and 9.7 percent (n = 890) had MBL. After adjusting for multiple potential confounders (including perioperative adverse events), MBL was associated with an 8.1-fold (95% confidence interval, 3.9-17.0) increase in the odds of death. This risk estimate was stable across different modeling conditions as well as in bootstrap sampling.ConclusionMBL after cardiac surgery has a strong, independent association with in-hospital mortality.

23 keywords...

hide…